Form 4: Gilead Sciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Erin Burkhart, SVP, Controllership of Gilead Sciences, Inc., reported multiple transactions in common stock on September 22, 2026.
Summary
- Option exercise/conversion: acquired 2,223 Common Stock on September 22, 2026; holds 2,223 after (Direct).
- Tax/exercise-price withholding: disposed of 768 Common Stock at $152.67 ($117,251) on September 22, 2026; holds 1,455 after (Direct).
- Option exercise/conversion: disposed of 2,223 Restricted Stock Unit on September 22, 2026; holds 9,022 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Erin Burkhart — Officer (SVP, Controllership)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-22 | Option exercise/conversion | Common Stock | 2,223 | — | — | 2,223 |
| 2026-09-22 | Tax/exercise-price withholding | Common Stock | 768 | $153 | $117.3K | 1,455 |
| 2026-09-22 | Option exercise/conversion | Restricted Stock Unit | 2,223 | — | — | 9,022 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-22 | Option exercise/conversion (2,223 shares) |
| 2026-09-22 | Tax/exercise-price withholding (768 shares) |
| 2026-09-22 | Option exercise/conversion (2,223 shares) |
Keywords
insider transaction, Form 4, GILD, GILEAD SCIENCES, INC., neutral, Erin Burkhart
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.